The nonprofit health organization’s MediMap tests were used by physicians in the Inova Genomics Laboratory to predict drug dosage, side effects and efficiency for patients.
On April 4, the FDA issued a letter to Inova warning that claims on the lab’s website were in violation of the Federal Food, Drug, and Cosmetic Act. Though Inova claimed the MediMap tests could predict patient responses to drugs, the FDA noted that it had not approved the tests’ safety and accuracy.
More articles on health IT:
Harvard Medical School’s AI screening system could produce more accurate cancer treatment programs
Microsoft emails users about data breach within customer support platform
California nursing program uses human-like robots to train medical personnel
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
